Evasion from accelerated blood clearance of nanocarrier named as "lactosome" induced by excessive administration of Lactosome

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 8, 2013, Pages 4046-4052

  Hara, Eri ^a   Makino, Akira ^b   Kurihara, Kensuke ^a   Sugai, Manabu ^a   Shimizu, Akira ^a   Hara, Isao ^c   Ozeki, Eiichi ^c   Kimura, Shunsaku ^d  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c SHIMADZU CORPORATION   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

ABC phenomenon; Immune tolerance; Molecular imaging; Nanoparticle

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; INDOCYANINE GREEN; LACTOSOME; NANOCARRIER; POLYLACTIC ACID; UNCLASSIFIED DRUG;

ACCELERATED BLOOD CLEARANCE PHENOMENON; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PHENOMENOLOGY; PLASMA CLEARANCE; PRIORITY JOURNAL; TISSUE LEVEL;

ANIMALS; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN M; LACTIC ACID; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED BALB C; MICELLES; NANOPARTICLES; PEPTIDES; POLYMERS; SARCOSINE;

MUS;

EID: 84877805205     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.03.024     Document Type: Article

References (27)

1. T. Lammers, W.E. Hennink, and G. Storm Tumour-targeted nanomedicines: principles and practice Br. J. Cancer 99 2008 392 397
2. N. Nishiyama, S. Okazaki, H. Cabral, M. Miyamoto, Y. Kato, Y. Sugiyama, K. Nishio, Y. Matsumura, and K. Kataoka Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice Cancer Res. 63 2003 8977 8983 (Pubitemid 38064079)
3. J. Fang, H. Nakamura, and H. Maeda The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Deliv. Rev. 63 2011 136 151
4. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer-chemotherapy - mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392 (Pubitemid 17221789)
5. A. Makino, S. Kizaka-Kondoh, R. Yamahara, I. Hara, T. Kanzaki, E. Ozeki, M. Hiraoka, and S. Kimura Near-infrared fluorescence tumor imaging using nanocarrier composed of poly(l-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide Biomaterials 30 2009 5156 5160
6. E. Hara, A. Makino, K. Kurihara, F. Yamamoto, E. Ozeki, and S. Kimura Pharmacokinetic change of nanoparticulate formulation "Lactosome" on multiple administrations Int. Immunopharmacol. 14 2012 261 266
7. E.T.M. Dams, P. Laverman, W.J.G. Oyen, G. Storm, G.L. Scherphof, J.W.M. Van der Meer, F.H.M. Corstens, and O.C. Boerman Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes J. Pharmacol. Exp. Ther. 292 2000 1071 1079 (Pubitemid 30136603)
8. T. Ishida, T. Ichikawa, M. Ichihara, Y. Sadzuka, and H. Kiwada Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected pegylated liposomes in mice J. Control. Release 95 2004 403 412 (Pubitemid 38340491)
9. T. Ishida, X. Wang, T. Shimizu, K. Nawata, and H. Kiwada PEGylated liposomes elicit an anti-PEG IgM response in a t cell-independent manner J. Control. Release 122 2007 349 355 (Pubitemid 47407760)
10. H. Koide, T. Asai, K. Hatanaka, S. Akai, T. Ishii, E. Kenjo, T. Ishida, H. Kiwada, H. Tsukada, and N. Oku T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes Int. J. Pharm. 392 2010 218 223
11. T. Ishihara, T. Maeda, H. Sakamoto, N. Takasaki, M. Shigyo, T. Ishida, H. Kiwada, Y. Mizushima, and T. Mizushima Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers Biomacromolecules 11 2010 2700 2706
12. H.L. Ma, K. Shiraishi, T. Minowa, K. Kawano, M. Yokoyama, Y. Hattori, and Y. Maitani Accelerated blood clearance was not induced for a gadolinium-containing peg-poly(l-lysine)-based polymeric micelle in mice Pharm. Res. 27 2010 296 302
13. J.J. Mond, A. Lees, and C.M. Snapper T-cell-independent antigens type-2 Annu. Rev. Immunol. 13 1995 655 692
14. J.J. Mond, Q. Vos, A. Lees, and C.M. Snapper T-cell independent antigens Curr. Opin. Immunol. 7 1995 349 354
15. X.Y. Wang, T. Ishida, and H. Kiwada Anti-peg igm elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of pegylated liposomes J. Control. Release 119 2007 236 244 (Pubitemid 46759557)
16. T. Ishida, and H. Kiwada Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes Int. J. Pharm. 354 2008 56 62
17. T. Ishida, M. Harada, X.Y. Wang, M. Ichihara, K. Irimura, and H. Kiwada Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes J. Control. Release 105 2005 305 317 (Pubitemid 40941995)
18. T. Ishida, K. Atobe, X.Y. Wang, and H. Kiwada Accelerated blood clearance of pegylated liposomes upon repeated injections: effect of doxorubicin- encapsulation and high-dose first injection J. Control. Release 115 2006 251 258 (Pubitemid 44634849)
19. K. Taguchi, Y. Urata, M. Anraku, H. Watanabe, D. Kadowaki, H. Sakai, H. Horinouchi, K. Kobayashi, E. Tsuchida, T. Maruyama, and M. Otagiri Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice Drug Metab. Dispos. 37 2009 2197 2203
20. A. Makino, E. Hara, I. Hara, R. Yamahara, K. Kurihara, E. Ozeki, F. Yamamoto, and S. Kimura Control of in vivo blood clearance time of polymeric micelle by stereochemistry of amphiphilic polydepsipeptides J. Control. Release 161 2012 821 825
21. A. Makino, R. Yamahara, E. Ozeki, and S. Kimura Preparation of novel polymer assemblies, "Lactosome", composed of poly(l-lactic acid) and poly(sarcosine) Chem. Lett. 36 2007 1220 1221
22. Z. Amoozgar, and Y. Yeo Recent advances in stealth coating of nanoparticle drug delivery systems Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4 2012 219 233
23. A.K. Abbas, and A.H. Lichtman Cellular and molecular immunology 5th edition 2003 Saunders
24. A. Friedman, and H.L. Weiner Induction of anergy or active suppression following oral tolerance is determined by antigen dosage Proc. Natl. Acad. Sci. U.S.A. 91 1994 6688 6692 (Pubitemid 24200727)
25. D.E. Mosier, and B. Subbarao Thymus-independent antigens - complexity of lymphocyte-b activation revealed Immunol. Today 3 1982 217 222
26. K.R. Alugupalli, J.M. Leong, R.T. Woodland, M. Muramatsu, T. Honjo, and R.M. Gerstein B1b lymphocytes confer T cell-independent long-lasting immunity Immunity 21 2004 379 390 (Pubitemid 39208339)
27. T.V. Obukhanych, and M.C. Nussenzweig T-independent type ii immune responses generate memory b cells J. Exp. Med. 203 2006 305 310 (Pubitemid 43290839)